spacer
home > > summer 2009 > feasibility studies: the road to success
PUBLICATIONS


Feasibility Studies: The Road to Success

In the extremely competitive world of the pharmaceutical industry, success often means being the first. And being the first means launching your new product on the market while leaving your competitors behind. In clinical research, the recruitment of the right patient population within the planned timelines is the most important factor in ensuring success. And because ‘time is money’, respecting timelines also means remaining within the available budget allocated for a clinical research project: this is what a sponsor expects from a CRO and this is what a CRO should be ready to offer to the pharmaceutical industry.

The selection of the right countries and investigational sites is the leading factor for a successful trial. Even when the regulatory process takes longer than expected, these appropriately chosen sites will help you in recovering this extra time by reducing the recruitment period and ensuring 100 per cent of patients are enrolled within timelines.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer

Margherita Mosconi is the Client Project Operations Director of CROM srl. After her PhD in Biological Science, she joined a major global pharmaceutical company and, over the subsequent 11 years, progressed through roles in national and international project management in a variety of therapeutic areas. She then joined CROM in January 2005 and has since overseen the operational delivery of hundreds of trials at all phases of development. Margherita is now responsible for new business opportunities and oversees the contracts, bids and proposals. She also liaises and works closely with CROM clients to optimise ongoing operational processes.

Davide Garrisi is Clinical Research Leader of the International Trials Department of CROM srl. Before joining CROM in 2005, he spent two years in quality assurance and regulatory affairs in the bulk pharmaceutical industry, where he was responsible for validation activities, quality system management (ISO, GMP), regulatory applications of drug master files, and having contact with regulatory authorities. He was also member of the internal Quality System Inspectors Team. Davide is now responsible for the supervision and management of several clinical trials in a variety of therapeutic fields.

spacer
Margherita Mosconi
spacer
spacer
spacer
Davide Garrisi
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Sustainability is a winner HERMA receives Packaging Award 2020

 • The PE label made entirely from post-consumer recycle material (PCR) wins the German Packaging Award in the “Sustainability” category. • Made with HERMA wash-off adhesive, this label opens up completely new high-quality recycling opportunities for plastic packaging. • The pioneering innovation is the result of the successful collaboration with schäfer-etiketten and Polifilm.
More info >>

White Papers

Nasal Drug Delivery with a Focus on Chronic Rhino-Sinusitis

Aptar Pharma

Aptar Pharma have hosted a scientific roundtable on “Nasal drug delivery with a focus on chronic rhino‑sinusitis”. This international scientific forum was held in Paris, France on November 13th 2012. The roundtable was organized to explore and exchange views on the science of various forms of sinusitis and its related unmet medical needs.
More info >>

 
Industry Events

CPhI Festival of Pharma

5-16 October 2020, Virtual

A virtual gathering for the pharmaceutical industry, the CPhI Festival of Pharma has been created to fill the gap left by in-person events at a time when travel and gatherings are off the cards.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement